Post-COVID syndrome: A prospective study in a tertiary hospital of Nepal

被引:5
|
作者
Shah, Sangam [1 ]
Bhattarai, Shreeyash Raj [1 ]
Basnet, Kriti [1 ]
Adhikari, Yagya Raj [2 ]
Adhikari, Tara Ballav [3 ,4 ,5 ]
Bhatta, Nikita [6 ]
Chamlagain, Rajan [2 ]
Aryal, Susan [2 ]
Sah, Sanjit Kumar [2 ]
Bhandari, Govinda [2 ]
Bhandari, Bibek [7 ]
Poudel, Sujan [8 ]
Pant, Pankaj [9 ]
Das, Santa Kumar [9 ]
机构
[1] Tribhuvan Univ, Maharajgunj Med Campus, Inst Med, Kathmandu, Nepal
[2] Tribhuvan Univ, Teaching Hosp, Kathmandu, Nepal
[3] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark
[4] Nepal Hlth Frontiers, Kathmandu, Nepal
[5] Nepal Dev Soc, COBIN Project, Chitwan, Nepal
[6] Tribhuvan Univ, Maharajgunj Nursing Campus, Inst Med, Kathmandu, Nepal
[7] Tribhuvan Univ, Inst Med, Dept Internal Med, Kathmandu, Nepal
[8] Larkins Community Hosp, Div Res & Acad Affairs, South Miami, FL USA
[9] Tribhuvan Univ, Maharajgunj Med Campus, Inst Med, Dept Pulmonol & Crit Care, Kathmandu, Nepal
来源
PLOS ONE | 2022年 / 17卷 / 08期
关键词
SURVIVORS; ILLNESS;
D O I
10.1371/journal.pone.0272636
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
IntroductionThe post-coronavirus disease 2019 (COVID-19) syndrome is defined as the persistence of symptoms after viral clearance and the emergence of new symptoms after a few months following recovery from COVID-19. This study aimed to assess the prevalence of post-COVID-19 syndrome and the risk factors that contribute to its development. MethodsThis study was conducted prospectively in Tribhuvan University Teaching Hospital (TUTH), located in Maharajgunj, Kathmandu. The patients were followed up for three months. ResultsThe post-COVID status of 300 patients admitted to the COVID emergency of TUTH was studied. The mean age of the patients was 46.6 +/- 15.7 years, and the proportion of male (56%) was slightly higher than female (44%). Most of the patients (81.7%) had fever on their presentation to the emergency which was followed by fatigue (81.3%) and cough (78.3%). During the post-COVID phase, fatigue was the most common persistent symptom, with 34% experiencing fatigue after 60 days and 28.3% even after 90 days from the onset of symptoms. Univariate logistic regression showed sore throat (OR 4.6; 95% CI (2.8-7.6)), rhinitis (OR 3.6; 95% CI (2.1-5.9)), fatigue (OR 3.7; 95% CI (1.8-7.6)), diarrhea (OR 4.1; 95% CI (2.4-6.9)), anosmia (OR 6.7; 95% CI (3.9-11.3)), ageusia (OR 7.8; 95% CI (4.5-13.4)) and shortness of breath (OR 14.9; 95% CI (1.8-119.6)) at admission were all predictors of post-COVID syndrome after three months. ConclusionEven after recovering from COVID-19, people with COVID-19 may develop symptoms. As a result, COVID-19's long-term consequences should not be neglected, as they may lead to increased morbidity among patients, consumption of financial resources, and added burden on the health system.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Post-Covid Asthenia Syndrome
    Khaibullina D.K.
    Maksimov Y.N.
    [J]. Neuroscience and Behavioral Physiology, 2023, 53 (8) : 1347 - 1354
  • [22] Opinion on Post-COVID Syndrome
    不详
    [J]. REHABILITATION, 2023, 62 (02) : 68 - 68
  • [23] Analysis of post-COVID symptoms and predisposing factors for chronic post-COVID syndrome
    Abali, Hulya
    Demir, Dilara
    Gul, Sule
    Veske, Nurdan Simsek
    Onur, Seda Tural
    [J]. TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2023, 71 (04): : 378 - 389
  • [24] Characterizing post-covid conditions in a Turkish cohort: A prospective study
    Emecen, A. N.
    Turunc, O.
    Sivye, N.
    Suner, A. F.
    Sensoy, E. Basoglu
    Keskin, S.
    Unal, B.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 32
  • [25] Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study
    Augustin, Max
    Schommers, Philipp
    Stecher, Melanie
    Dewald, Felix
    Gieselmann, Lutz
    Gruell, Henning
    Horn, Carola
    Vanshylla, Kanika
    Di Cristanziano, Veronica
    Osebold, Luise
    Roventa, Maria
    Riaz, Toqeer
    Tschernoster, Nikolai
    Altmueller, Janine
    Rose, Leonard
    Salomon, Susanne
    Priesner, Vanessa
    Luers, Jan Christoffer
    Albus, Christian
    Rosenkranz, Stephan
    Gathof, Birgit
    Faetkenheuer, Gerd
    Hallek, Michael
    Klein, Florian
    Suarez, Isabelle
    Lehmann, Clara
    [J]. LANCET REGIONAL HEALTH-EUROPE, 2021, 6
  • [26] Post-COVID syndrome or persistent COVID and depression
    Castelao-Almodovar, S.
    Ojea Quintana, R.
    Arrieta Artigas, A.
    Arce de la Riva, A.
    Tejero Soriano, B.
    [J]. EUROPEAN PSYCHIATRY, 2023, 66 : S806 - S807
  • [27] Pharmacovigilance study of amphotericin B for mucormycosis in post-COVID and non-COVID patients at a tertiary care hospital in Eastern India
    Chatterjee, Suparna
    Bhattacharjee, Manjari
    Hazra, Avijit
    Mukhopadhyay, Pradip
    Ray, Biman Kanti
    Chatterjee, Sayan
    Dubey, Souvik
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2022, 54 (06) : 417 - 422
  • [28] Post-COVID care delivery: The experience from an Irish tertiary centre's post-COVID clinic
    Heeney, Aoife
    Connolly, Stephen P.
    Dillon, Rachel
    O'Donnell, Aisling
    McSweeney, Tara
    O'Kelly, Brendan
    Cotter, Aoife G.
    Sheehan, Gerard
    Lambert, John S.
    Muldoon, Eavan G.
    McGinty, Tara
    [J]. PLOS ONE, 2023, 18 (08):
  • [29] Post-COVID syndrome, inflammation, and diabetes
    Rizvi, Ali A.
    Kathuria, Amita
    Al Mahmeed, Wael
    Al-Rasadi, Khalid
    Al-Alawi, Kamila
    Banach, Maciej
    Banerjee, Yajnavalka
    Ceriello, Antonio
    Cesur, Mustafa
    Cosentino, Francesco
    Galia, Massimo
    Goh, Su-Yen
    Janez, Andrej
    Kalra, Sanjay
    Kempler, Peter
    Lessan, Nader
    Lotufo, Paulo
    Papanas, Nikolaos
    Santos, Raul D.
    Stoian, Anca P.
    Toth, Peter P.
    Viswanathan, Vijay
    Rizzo, Manfredi
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (11)
  • [30] Autoimmunity is a hallmark of post-COVID syndrome
    Manuel Rojas
    Yhojan Rodríguez
    Yeny Acosta-Ampudia
    Diana M. Monsalve
    Chengsong Zhu
    Quan-Zhen Li
    Carolina Ramírez-Santana
    Juan-Manuel Anaya
    [J]. Journal of Translational Medicine, 20